We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$40.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38M
3
META icon
Meta Platforms (Facebook)
META
+$23.2M
4
ORCL icon
Oracle
ORCL
+$20.4M
5
MJN
Mead Johnson Nutrition Company
MJN
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WU icon
501
Western Union
WU
$2.57B
$1.47M 0.03%
76,999
+10,259
+15% +$199K
ASRT
502
DELISTED
Assertio
ASRT
$1.46M 0.03%
2,271
+1,917
+542% +$1.28M
TTPH
503
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.43M 0.03%
10,050
– –
VTR icon
504
Ventas
VTR
$48.9B
$1.43M 0.03%
20,538
– –
CXO
505
DELISTED
CONCHO RESOURCES INC.
CXO
$1.42M 0.03%
11,643
+899
+8% +$114K
INO icon
506
Inovio Pharmaceuticals
INO
$79.8M
$1.41M 0.03%
+15,000
New +$1.28M
SGMO
507
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.41M 0.03%
160,000
-110,000
-41% -$706K
INFO
508
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.41M 0.03%
31,975
+4,090
+15% +$182K
ACOR
509
DELISTED
Acorda Therapeutics
ACOR
$1.4M 0.03%
592
– –
KB icon
510
KB Financial Group
KB
$41.2B
$1.39M 0.03%
+27,500
New +$1.28M
GWW icon
511
W.W. Grainger
GWW
$65.3B
$1.39M 0.03%
7,670
+1,139
+17% +$215K
CLX icon
512
Clorox
CLX
$11.6B
$1.36M 0.03%
10,196
-195
-2% -$26.3K
ORLY icon
513
O'Reilly Automotive
ORLY
$72.4B
$1.36M 0.03%
92,955
– –
ADSK icon
514
Autodesk
ADSK
$44.3B
$1.35M 0.03%
13,348
+1,020
+8% +$101K
MDRX
515
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.34M 0.03%
105,000
– –
ALDR
516
DELISTED
Alder Biopharmaceuticals
ALDR
$1.34M 0.03%
117,000
+8,000
+7% +$148K
CERN
517
DELISTED
Cerner Corp
CERN
$1.33M 0.03%
19,999
-74,670
-79% -$4.77M
DISH
518
DELISTED
DISH Network Corp.
DISH
$1.32M 0.02%
21,000
– –
ESS icon
519
Essex Property Trust
ESS
$18.9B
$1.31M 0.02%
5,093
+214
+4% +$53.8K
RHT
520
DELISTED
Red Hat Inc
RHT
$1.29M 0.02%
13,484
-598
-4% -$53.4K
CTAS icon
521
Cintas
CTAS
$82.4B
$1.29M 0.02%
40,796
+916
+2% +$28.5K
LPL icon
522
LG Display
LPL
$3.17B
$1.29M 0.02%
80,000
-120,000
-60% -$1.71M
WEC icon
523
WEC Energy
WEC
$37.7B
$1.29M 0.02%
20,953
– –
IMO icon
524
Imperial Oil
IMO
$62.1B
$1.28M 0.02%
43,863
+6,598
+18% +$193K
NOW icon
525
ServiceNow
NOW
$102B
$1.25M 0.02%
58,795
+2,690
+5% +$52.7K
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.